Mon, Jun 29th, 2009
Related topics:
Shares of Biogen Idec sank Monday after the biotechnology giant confirmed that another patient taking the multiple sclerosis drug Tysabri has been diagnosed with a potentially fatal brain infection called progressive multifocal leukoencephalopathy, or PML.
The patient, who lives overseas and had been taking Tysabri for more than 30 months, is the 10th person to come down with PML since the multiple sclerosis drug was allowed back onto pharmacy shelves in 2006. Three of those cases have been diagnosed this month.
Related stories from top sites:
LDK Solar disappoints with Q2 revenue forecast
Jun 26th, 2009 - Reuters
LOS ANGELES (Reuters) - China's LDK Solar on Thursday forecast lower-than-expected second-quarter revenue, as demand for solar cells stays depressed and solar manufacturers struggle to secure financing.
Dish get stay, TiVo shares fall Silicon Valley / San Jose Business ...
Jun 26th, 2009 - bizjournals
TiVo Inc. shares fell more than 15 percent late Thursday after a ruling that customers of Dish Network Corp. can still use their digital video recorders, at least temporarily.
United Air Lines sets price for note offering
Jun 26th, 2009 - The Seattle Times
United Air Lines Inc. announced Monday the pricing of its offering of $175 million in principal senior secured notes. The company said the notes were issued at a discount to their face value and carry a coupon of 12.
Microsoft Windows 7 Price Cut Seen As Good Strategic Move
Jun 26th, 2009 - Wall Street Journal
Shares of Microsoft Corp. (MSFT) fell a day after the software giant said a price cut will be offered as part of its impending release of a new version of Windows. Microsoft said Thursday it will cut prices for the consumer version of Windows 7...
UPDATE 1-Altria says UST CEO Kessler to leave
Jun 26th, 2009 - Reuters
* UST CEO to leave Altria at the end of June * Altria says integration cost savings on track * Altria shares fall 0.7 percent CHICAGO, June 26 (Reuters) - Smokeless tobacco maker UST'stop executive will leave Altria Group Inc (MO.
Related videos from YouTube:
- Living with MS: My FIRST...I would like to share with all you my FIRST Tysabri infusion! This is the fourth medication that I am taking to try to slow the progression of my MS. Here is my experience...
- my MS- taking TysabriI decided to take Tysabri and I want to share side effects, improvements and impressions with you- this is the video I made after my first Infusion! If you have questions feel free to write me a mail- you are welcome :-)
- Tysabri My 12th InfusionThis is my first video EVER! So it is not that good. I am trying to share my life with MS and how Tysabri is working for me.
- Bullish Case for Elan: MS...Exclusive Report - MS Patients Not Fleeing Tysabri; According to Ian Hunter of Goodbody Stockbrokers, Elan Stock Will Rebound by Year End, Recommending Adding to Shares; Elan and Biogen Expect $3 Billion in Tysabri Sales by 2010 ...
Related stories from Digg:
SEC Subpoenas Elan For Records Of Tysabri Infection Cases
Irish drug maker Elan Corp. Plc (ELN) said Tuesday it received a subpoena from the U.S. Securities and Exchange Commission seeking information related to disclosures last year about Elan's multiple-sclerosis drug Tysabri and an experimental Alzheimer's disease drug - disclosures that battered Elan shares.(Health)
cluccaTue, Sep 29th, 20091 Diggs, 0 CommentsPartners Behind an MS Drug Take Their Dispute to Court
Biogen says its partner, Elan, has violated their deal to share ownership of the drug Tysabri. Elan says it has not.(Health)jfdevinejrSat, Aug 8th, 20091 Diggs, 0 CommentsAnother Tysabri Patient has PML | stocks
Biogen Idec Inc. reported late yesterday that another patient contracted a potentially fatal brain disease after taking the multiple sclerosis drug Tysabri, the third case since the biotechnology giant reintroduced the treatment two years ago. The news sent shares tumbling 12.1 percent in after-hours trading.(Business & Finance)mezabytesFri, Oct 31st, 20082 Diggs, 0 Comments
Leave a Reply